(D-Pro2,D-Trp7·9)-Substance P acetate salt

Modify Date: 2025-08-26 17:53:24

(D-Pro2,D-Trp7·9)-Substance P acetate salt Structure
(D-Pro2,D-Trp7·9)-Substance P acetate salt structure
Common Name (D-Pro2,D-Trp7·9)-Substance P acetate salt
CAS Number 80434-86-2 Molecular Weight 1515.82000
Density N/A Boiling Point N/A
Molecular Formula C74H106N20O13S Melting Point N/A
MSDS USA Flash Point N/A

 Use of (D-Pro2,D-Trp7·9)-Substance P acetate salt


[D-Pro2,D-Trp7,9] Substance P, a Substance P (HY-P0201) analogue, is a weak agonist and a potent, specific, competitive Substance P antagonist[1][2].

 Names

Name [d-pro2, d-trp7,9]-substance p
Synonym More Synonyms

  Biological Activity

Description [D-Pro2,D-Trp7,9] Substance P, a Substance P (HY-P0201) analogue, is a weak agonist and a potent, specific, competitive Substance P antagonist[1][2].
Related Catalog
In Vitro [D-Pro2,D-Trp7,9] Substance P decreases proliferation only in a few cell lines, and only in the highest concentration (100 µM). [D-Pro2,D-Trp7,9] Substance P displays a significantly weaker antiproliferative action than Aprepitant (HY-10052) on cancer or normal cell lines[3].
In Vivo [D-Pro2,D-Trp7,9] Substance P (0-30 nmol, Intravitreal injection) greatly reduces not only the effects of exogenous Substance P (HY-P0201) but also the inflammatory response to trauma to the eye[1]. [D-Pro2,D-Trp7,9] Substance P specifically antagonizes the contractile effects of Substance P on the guinea-pig isolated taenia coli[2]. Animal Model: Adult pigmented rabbits (1.5-3 kg)[1] Dosage: 0.03, 0.3, 3, and 30 nmol Administration: Intravitreal injection or topical application onto the eye, 60 μL Result: Reduced the inflammatory response to Substance P. Dependently reduced the inflammatory response to infrared irradiation. In itself, intravitreal injection of low doses of [D-Pro2, D-Trp7'9]SP had no effects on the eye.
References

[1]. Holmdahl G, et al. A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye. Science. 1981 Nov 27;214(4524):1029-31.  

[2]. Håkanson R, et al. The mechanism of action of a substance P antagonist (D-Pro2, D-Trp7,9)-SP. Br J Pharmacol. 1982 Dec;77(4):697-700.  

[3]. Matalińska J, et al. Antiproliferative effects of [D-Pro2, D-Trp7,9]-Substance P and aprepitant on several cancer cell lines and their selectivity in comparison to normal cells. Folia Neuropathol. 2020;58(3):237-244. English.  

 Chemical & Physical Properties

Molecular Formula C74H106N20O13S
Molecular Weight 1515.82000
Exact Mass 1514.80000
PSA 573.51000
LogP 6.76800

 Synonyms

2-Pro-7,9-Trp-substance p
2-Pro-7,9-Trp-sp
Pttsp
Pt-sp
<D-Pro2,D-Trp7,9>-SP
dt79
[DPro2,DTrp7,9] Substance P
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

(D-Pro2,D-Trp7·9)-Substance P acetate salt suppliers

(D-Pro2,D-Trp7·9)-Substance P acetate salt price

Related Compounds: More...
(D-Arg1,D-Pro2,D-Trp7·9,Leu11)-Substance P
84676-91-5
[D-Pro2,D-Phe7,D-Trp9]-Substance P
77275-70-8
[D-Arg1,D-Pro2,D-Phe7,D-His9]-Substance P
115760-58-2
substance p acetate salt hydrate, biochemika
137348-11-9
(D-Pro2,D-Trp6.8,Nle10)-Neurokinin B
109212-72-8
Spantide I TFA
91224-37-2
Substance P acetate salt
33507-63-0
(D-Lys(nicotinoyl)1,β-(3-pyridyl)-Ala3,3,4-dichloro-D-Phe5,Asn6,D-Trp7·9,Nle11)-Substance P trifluoroacetate salt
129176-97-2
(D-Pro4,D-Trp7·9·10)-Substance P (4-11)
86917-57-9
1-(1-{1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}azetidin-3-yl)-2-(propan-2-yl)-1H-1,3-benzodiazole
2415585-64-5
1-Phenyl-3-(1-{thieno[3,2-d]pyrimidin-4-yl}azetidin-3-yl)urea
2415585-71-4
2-(propan-2-yl)-1-{1-[(1,3,5-trimethyl-1H-pyrazol-4-yl)sulfonyl]azetidin-3-yl}-1H-1,3-benzodiazole
2415565-67-0
N-[(furan-2-yl)methyl]-N'-{[4-(thiomorpholin-4-yl)oxan-4-yl]methyl}ethanediamide
2415513-94-7
N-(5-methyl-1,2-oxazol-3-yl)-N'-{[4-(thiomorpholin-4-yl)oxan-4-yl]methyl}ethanediamide
2415503-30-7
1-[(1-ethyl-3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-{6-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}piperidine
2415491-75-5
1-{1-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonyl]azetidin-3-yl}-2-(propan-2-yl)-1H-1,3-benzodiazole
2415564-13-3
5-bromo-2-chloro-N-{[4-(thiomorpholin-4-yl)oxan-4-yl]methyl}benzamide
2415532-77-1
5-({3-[(5-Fluoro-6-methylpyrimidin-4-yl)(methyl)amino]piperidin-1-yl}sulfonyl)-2,3-dihydro-1,3-benzoxazol-2-one
2415513-16-3
5,6-dimethyl-N-(3-{[1,2,4]triazolo[4,3-b]pyridazin-6-yl}phenyl)pyrimidine-4-carboxamide
2415454-75-8